These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5722353)

  • 1. Gefarnate.
    Drug Ther Bull; 1968 Nov; 6(24):94-5. PubMed ID: 5722353
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study of the effect of geranyl of farnesylacetate combined with nafiver in peptic ulcer patients].
    Mincis M
    Rev Bras Med; 1968 May; 25(5):324-7. PubMed ID: 5724217
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gefarnate in the therapy of peptic ulcer].
    Ortone G; Furno F
    Minerva Med; 1968 Dec; 59(101):5647-62. PubMed ID: 5707471
    [No Abstract]   [Full Text] [Related]  

  • 4. A double-blind trial of oral gefarnate in duodenal ulcer.
    Newman CR; Montgomery DA
    Br J Clin Pract; 1973 Mar; 27(3):85-6. PubMed ID: 4580209
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gefarnate (DA-688) in the treatment of peptic ulcer; immediate results].
    Lima JP; da Silveira TR; Kerz L
    Rev Bras Med; 1966 Mar; 23(3):193-8. PubMed ID: 5940586
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analysis of the value of the product geranyl farnesyl acetate (Gefarnate) in the treatment of peptic ulcer].
    Nery AL; Nascif R
    Hospital (Rio J); 1966 Apr; 69(4):669-89. PubMed ID: 5295886
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of chronic gastric ulcer with carbenoxolone and gefarnate: a comparative trial.
    Langman MJ; Knapp DR; Wakley EJ
    Br Med J; 1973 Jul; 3(5871):84-6. PubMed ID: 4577839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endoscopic study of clinical trials of geranyl farnesylacetate].
    Da Grada CT; Greco O; Campagnoli P
    Minerva Gastroenterol; 1967; 13(4):157-64. PubMed ID: 5607546
    [No Abstract]   [Full Text] [Related]  

  • 9. [THERAPY OF PEPTIC ULCER WITH GEFARNATE, GERANYL FARNESYL ACETATE].
    GOUVEIA OF; GALPER E; DA CUNHA M; TEIXEIRA D
    Rev Bras Med; 1965 Feb; 22():85-94. PubMed ID: 14336325
    [No Abstract]   [Full Text] [Related]  

  • 10. The Mann-Williamson ulcer as a model for testing antiulcer drugs. Results obtained with gefarnate.
    Ichiki H; Isoda M
    Arzneimittelforschung; 1973 Mar; 23(3):461-3. PubMed ID: 4740136
    [No Abstract]   [Full Text] [Related]  

  • 11. [OUR EXPERIENCE WITH "GEFARNIL" IN THE PEPTIC ULCER].
    GONZALEZCAMPOS C; GUTIERREZGUTIERREZ L
    Rev Clin Esp; 1964 Dec; 95():377-84. PubMed ID: 14268082
    [No Abstract]   [Full Text] [Related]  

  • 12. [CLINICAL EVALUATION OF A NEW ANTI-ULCER PRODUCT (GERANYL FARNESYLACETATE)].
    BERTERO R; SARACCO C; BRUNO G
    Minerva Gastroenterol; 1963; 9():158-65. PubMed ID: 14094498
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinicobiological evolution of duodenal ulcer treated with gefarnate].
    Pastor Franco A
    Rev Clin Esp; 1966 Jan; 100(1):50-8. PubMed ID: 4286000
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis of 14C-labelled geranyl farnesylacetate (gefarnate).
    Coppi G; Bonardi G
    Arzneimittelforschung; 1969 Sep; 19(9):1518-9. PubMed ID: 5394524
    [No Abstract]   [Full Text] [Related]  

  • 15. ESTERS OF FARNESYLACETIC ACID.
    CARDANI C; CAVALLERI B; ADAMI E
    J Med Chem; 1963 Jul; 6():457-8. PubMed ID: 14184908
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antiulcerous effect of various esters of farnesylacetic acid on the gastric mucosa in guinea pigs and rats].
    Smejkal V; Dlabac A; Trcka V
    Cesk Gastroenterol Vyz; 1966 Apr; 20(3):154-7. PubMed ID: 5934910
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of cimetidine on the treatment of acid-peptic disease.
    Fleshler B
    Prim Care; 1981 Jun; 8(2):195-203. PubMed ID: 7027288
    [No Abstract]   [Full Text] [Related]  

  • 18. Essential fatty acids and peptic ulcer disease.
    Das UN; Reddy DN; Rao PN; Radha V
    Gut; 1987 Jul; 28(7):914-6. PubMed ID: 3653761
    [No Abstract]   [Full Text] [Related]  

  • 19. [Last generation hyperoxygenated fatty acids. A product to keep in mind in pressure ulcer prevention].
    Nadal MJ; García Rey J
    Rev Enferm; 2004 Jun; 27(6):74-5. PubMed ID: 15315103
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of peptic ulcer with antacids].
    Weiss W
    Wien Med Wochenschr; 1983; 133(4-5):112-5. PubMed ID: 6407214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.